Clinical trial
To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial) - An Open Label Placebo Randomized Control Trial
NCT05060523 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial) - An Open Label Placebo Randomized Control Trial
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 19, 2021
- Completion date
- September 30, 2022
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.